This Article Full Text Full Text (PDF) All Versions of this Article: 90/7/4163    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Féry, F. Articles by Balasse, E. O. Search for Related Content PubMed PubMed Citation Articles by Féry, F. Articles by Balasse, E. O. Related Collections Diabetes and Insulin Metabolism

Effect of Somatostatin on Duodenal Glucose Absorption in Man

Laboratory of Experimental Medicine and Physiopathology and Department of Endocrinology (F.F., E.O.B.), and Department of Gastroenterology (J.D.), Hôpital Erasme, University of Brussels, B-1070 Brussels, Belgium; and Institute of Physiology (L.T., P.S.), School of Medicine, University of Lausanne, CH-1005 Lausanne, Switzerland

Address all correspondence and requests for reprints to: F. Féry, Laboratory of Experimental Medicine, Brussels Free University, 808 Route de Lennik, B-1070 Brussels, Belgium. E-mail: ffery{at}ulb.ac.be.

Objective: The hyperglycemic hyperinsulinemic clamp technique using intraduodenally infused glucose is an attractive tool for studying postprandial glucose metabolism under strictly controlled conditions. Because it requires the use of somatostatin (SST), we examined, in this study, the effect of SST on intestinal glucose absorption.

Context: Twenty-six normal volunteers were given a constant 3-h intraduodenal infusion of glucose (6 mg·kg^–1·min^–1) labeled with [2-³H]glucose for glucose absorption measurement. During glucose infusion, 19 subjects received iv SST at doses of 10–100 ng·kg^–1·min^–1 plus insulin and glucagon, and seven subjects were studied under control conditions. In the controls, glucose was absorbed at a rate that, after a 20-min lag period, equaled the infusion rate.

Results: With all the doses of SST tested, absorption was considerably delayed but equaled the rate of infusion after 3 h. At that time, only 5 ± 2% of the total amount of infused glucose was unabsorbed in the control subjects vs. 36 ± 2% (P < 0.001) in the SST-infused subjects. In the latter, the intraluminal residue was almost totally absorbed within 40 min of the cessation of SST infusion. At the lowest dose of SST tested (10 ng·kg^–1·min^–1), suppression of insulin secretion was incomplete.

Conclusion: These properties of SST hamper the use of intraduodenal hyperglycemic hyperinsulinemic clamps as a tool for exploring postprandial glucose metabolism.

This article has been cited by other articles:

				D. S. Edgerton, K. M. Stettler, D. W. Neal, M. Scott, L. Bowen, W. Wilson, C. H. Hobbs, C. Leach, T. R. Strack, and A. D. Cherrington Inhalation of Human Insulin Is Associated with Improved Insulin Action Compared with Subcutaneous Injection and Endogenous Secretion in Dogs J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1258 - 1264. [Abstract] [Full Text] [PDF]

				V. Rigalleau, M.-C. Beauvieux, J.-L. Gallis, H. Gin, P. Schneiter, and L. Tappy Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1198 - E1204. [Abstract] [Full Text] [PDF]